Wuxi Chemical Equipment Co., Ltd. (SHE:001332)
China · Delayed Price · Currency is CNY 56.05
-1.51 (-2.62%)
At close: Feb 13, 2026
Wuxi Chemical Equipment Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,316 | 1,524 | 1,240 | 1,163 | 1,007 | 830.38 |
Other Revenue | 9.36 | 9.36 | 8.76 | 6.59 | 5.83 | 4.89 |
| 1,325 | 1,534 | 1,248 | 1,170 | 1,013 | 835.27 | |
Revenue Growth (YoY) | -19.00% | 22.86% | 6.74% | 15.49% | 21.24% | 9.99% |
Cost of Revenue | 859.61 | 1,044 | 986.08 | 806.85 | 639.72 | 519.14 |
Gross Profit | 465.74 | 490.04 | 262.34 | 362.71 | 372.99 | 316.13 |
Selling, General & Admin | 125.13 | 109.48 | 82.96 | 67.61 | 57.52 | 52.61 |
Research & Development | 51.74 | 51.69 | 43.27 | 40.22 | 36.53 | 27.53 |
Other Operating Expenses | 10.59 | 12.34 | 0.13 | 7.51 | 8.3 | 10.41 |
Operating Expenses | 251.55 | 245.82 | 131.16 | 134.99 | 108.87 | 98.14 |
Operating Income | 214.19 | 244.22 | 131.19 | 227.71 | 264.12 | 217.99 |
Interest Expense | - | - | - | -0.08 | -0.43 | - |
Interest & Investment Income | 41.84 | 41.01 | 34.41 | 8.73 | 4.32 | 4.13 |
Currency Exchange Gain (Loss) | 3.5 | 3.5 | 4.8 | 19.41 | -4.94 | -3.24 |
Other Non Operating Income (Expenses) | 7.01 | -0.53 | -1.02 | -0.69 | -0.41 | -0.76 |
EBT Excluding Unusual Items | 266.54 | 288.19 | 169.37 | 255.08 | 262.67 | 218.12 |
Gain (Loss) on Sale of Investments | -0.36 | 0.46 | 0.32 | 0.53 | - | -0.51 |
Gain (Loss) on Sale of Assets | - | 0.02 | 0.01 | 0.01 | 0 | 0.01 |
Asset Writedown | 15.42 | -1.6 | -0.22 | -0 | -0 | -0.23 |
Other Unusual Items | 6.36 | 6.36 | 19.06 | 8.47 | 2.34 | 6.99 |
Pretax Income | 287.97 | 293.44 | 188.53 | 264.1 | 265 | 224.39 |
Income Tax Expense | 40.97 | 38.27 | 23.53 | 33.59 | 35.71 | 31.3 |
Net Income | 247 | 255.16 | 165 | 230.5 | 229.29 | 193.09 |
Net Income to Common | 247 | 255.16 | 165 | 230.5 | 229.29 | 193.09 |
Net Income Growth | 1.11% | 54.64% | -28.42% | 0.53% | 18.75% | 15.48% |
Shares Outstanding (Basic) | 110 | 109 | 108 | 88 | 81 | 81 |
Shares Outstanding (Diluted) | 110 | 109 | 108 | 88 | 81 | 81 |
Shares Change (YoY) | 2.11% | 0.68% | 23.05% | 8.16% | 0.10% | 0.06% |
EPS (Basic) | 2.24 | 2.35 | 1.53 | 2.63 | 2.83 | 2.39 |
EPS (Diluted) | 2.24 | 2.35 | 1.53 | 2.63 | 2.83 | 2.39 |
EPS Growth | -0.98% | 53.60% | -41.83% | -7.05% | 18.63% | 15.41% |
Free Cash Flow | 251.89 | 186.09 | 194.11 | -128.5 | 117.75 | 192.95 |
Free Cash Flow Per Share | 2.29 | 1.71 | 1.80 | -1.47 | 1.45 | 2.38 |
Dividend Per Share | 0.800 | 1.000 | 0.500 | 2.593 | - | 1.111 |
Dividend Growth | -20.00% | 100.00% | -80.71% | - | - | - |
Gross Margin | 35.14% | 31.95% | 21.01% | 31.01% | 36.83% | 37.85% |
Operating Margin | 16.16% | 15.92% | 10.51% | 19.47% | 26.08% | 26.10% |
Profit Margin | 18.64% | 16.64% | 13.22% | 19.71% | 22.64% | 23.12% |
Free Cash Flow Margin | 19.00% | 12.13% | 15.55% | -10.99% | 11.63% | 23.10% |
EBITDA | 246.71 | 275.13 | 159.95 | 251.81 | 288.04 | 238.71 |
EBITDA Margin | 18.62% | 17.94% | 12.81% | 21.53% | 28.44% | 28.58% |
D&A For EBITDA | 32.52 | 30.91 | 28.76 | 24.09 | 23.91 | 20.72 |
EBIT | 214.19 | 244.22 | 131.19 | 227.71 | 264.12 | 217.99 |
EBIT Margin | 16.16% | 15.92% | 10.51% | 19.47% | 26.08% | 26.10% |
Effective Tax Rate | 14.23% | 13.04% | 12.48% | 12.72% | 13.48% | 13.95% |
Revenue as Reported | 1,325 | 1,534 | 1,248 | 1,170 | 1,013 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.